Castle Biosciences Inc. (CSTL)
21.34
-0.34 (-1.57%)
At close: Mar 03, 2025, 3:59 PM
21.27
-0.33%
After-hours: Mar 03, 2025, 04:54 PM EST
Castle Biosciences Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 119.71M | 98.84M | 122.95M | 329.63M | 409.85M | 98.84M | 4.48M | 1.21M |
| Short-Term Investments | 173.42M | 144.26M | 135.68M | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 1.09M | 1.31M | 1.1M | 870K | 2.53M | 1.56M |
| Other Long-Term Assets | 2.15M | 2.63M | -25.58M | 3.02M | 1.54M | 135K | 2.75M | 1.63M |
| Receivables | 51.22M | 38.3M | 23.48M | 17.28M | 12.76M | 14.65M | 12.09M | 4.65M |
| Inventory | 8.13M | 7.94M | 3.98M | 2.02M | 2.22M | 1.24M | 882.23K | 304.58K |
| Other Current Assets | 7.67M | 6.29M | 6.21M | 9.61M | 9.53M | 3.9M | 675K | 515.51K |
| Total Current Assets | 360.15M | 295.63M | 292.29M | 353.74M | 429.59M | 116.68M | 18.13M | 6.68M |
| Property-Plant & Equipment | 62.71M | 37.74M | 26.5M | 16.88M | 7.1M | 2.06M | 1.53M | 1.47M |
| Goodwill & Intangibles | 106.23M | 117.33M | 126.35M | 88.92M | n/a | n/a | 4.17K | 40.12K |
| Total Long-Term Assets | 171.08M | 157.71M | 155.04M | 108.83M | 9.73M | 3.06M | 4.28M | 3.14M |
| Total Assets | 531.24M | 453.34M | 447.33M | 462.57M | 439.33M | 119.75M | 22.4M | 9.82M |
| Account Payables | 6.9M | 10.27M | 4.73M | 2.55M | 2.1M | 1.86M | 1.45M | 1.12M |
| Deferred Revenue | n/a | n/a | n/a | n/a | 6.62M | n/a | n/a | 9.73K |
| Short-Term Debt | 1.94M | 1.14M | 3.55M | 2.36M | n/a | 5.83M | n/a | 1M |
| Other Current Liabilities | 39.47M | 36.26M | 27.81M | 19.29M | 12.1M | 7.51M | 5.28M | 3.08M |
| Total Current Liabilities | 49.39M | 47.67M | 36.13M | 24.89M | 20.88M | 15.29M | 6.74M | 5.22M |
| Long-Term Debt | 24.4M | 14.2M | 11.53M | 6.9M | n/a | 19.29M | 24.5M | 17.6M |
| Other Long-Term Liabilities | n/a | n/a | 90K | 18.41M | 1.03M | 55K | 1.24M | 1.27M |
| Total Long-Term Liabilities | 26.01M | 14.4M | 12.05M | 25.95M | 2.76M | 19.34M | 25.74M | 18.87M |
| Total Liabilities | 75.4M | 62.07M | 48.18M | 50.83M | 23.64M | 34.63M | 32.47M | 24.09M |
| Total Debt | 26.34M | 15.34M | 13.31M | 8.08M | n/a | 25.12M | 24.5M | 18.6M |
| Common Stock | 28K | 27K | 27K | 25K | 25K | 17K | 1.92K | 1.9K |
| Retained Earnings | -200.13M | -218.37M | -160.91M | -93.77M | -62.5M | -52.21M | -57.49M | -51.12M |
| Comprehensive Income | 230K | 136K | -381K | n/a | 0.00 | -119.75M | -909.38K | -638.47K |
| Shareholders Equity | 455.83M | 391.27M | 399.15M | 411.74M | 415.69M | 85.11M | -10.07M | -14.27M |
| Total Investments | 173.42M | 144.26M | 135.68M | 1.31M | 1.1M | 870K | 2.53M | 1.56M |